US Stock MarketDetailed Quotes

ADXS Ayala Pharmaceuticals

Watchlist

0.027000
0.0000000.00%

15min DelayClose Nov 22 16:00 ET

1.15MMarket Cap-3P/E (TTM)

Ayala Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

(Q4)Dec 31, 2021

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

14.56%-29.49M

11.83%-7.2M

25.22%-6.98M

10.03%-34.51M

-4.83%-8.17M

0.34%-9.34M

39.18%-7.02M

-3.47%-9.98M

-39.27%-38.36M

-11.75%-7.79M

Net income from continuing operations

-26.46%-48.07M

-152.62%-24.67M

27.94%-7.34M

5.57%-38.01M

2.81%-9.77M

-3.97%-10.19M

25.89%-8.03M

-4.80%-10.03M

-33.53%-40.25M

-6.93%-10.05M

Operating gains losses

--5.85M

--5.97M

---17K

----

Depreciation and amortization

127.78%369K

451.22%226K

10.00%44K

-3.57%162K

46.43%41K

-13.04%40K

172.86%51K

-81.71%30K

-7.69%168K

-36.36%28K

Other non cash items

--9.87M

--9.8M

----

Change In working capital

3.01%1.13M

18.00%1.45M

-40.82%174K

214.99%1.1M

-18.62%1.23M

281.48%294K

117.03%205K

42.57%-630K

-211.71%-954K

-20.87%1.51M

-Change in receivables

200.00%234K

--0

-134.36%-234K

-128.15%-105K

-76.08%133K

149.47%376K

-224.61%-638K

421.23%681K

505.43%373K

-Change in prepaid assets

-166.80%-1.49M

-91.21%99K

-94.27%45K

290.12%2.23M

202.69%1.13M

154.51%785K

-4,494.44%-827K

1,404.55%1.15M

-14.09%-1.17M

-57.97%372K

-Change in payables and accrued expense

498.01%2.6M

1,215.89%1.41M

126.65%145K

-41.65%-653K

-85.99%107K

-175.35%-544K

316.90%924K

25.05%-1.14M

-122.00%-461K

-40.17%764K

-Change in other current assets

396.18%1.43M

1,626.47%1.17M

140.82%118K

--288K

--68K

--49K

----

-Change in other current liabilities

-206.16%-1.64M

-3,950.00%-1.23M

-3.88%-134K

---536K

--32K

---129K

----

Cash from discontinued investing activities

Operating cash flow

14.56%-29.49M

11.83%-7.2M

25.22%-6.98M

10.03%-34.51M

-4.83%-8.17M

0.34%-9.34M

39.18%-7.02M

-3.47%-9.98M

-39.27%-38.36M

-11.75%-7.79M

Investing cash flow

Cash flow from continuing investing activities

297,400.00%5.95M

60.00%-2K

-102.76%-5K

Net PPE purchase and sale

----

88.89%-5K

--0

Net business purchase and sale

--1.91M

----

--0

----

Net investment purchase and sale

----

--0

----

Net other investing changes

201,950.00%4.04M

----

---2K

----

Cash from discontinued investing activities

Investing cash flow

297,400.00%5.95M

----

60.00%-2K

----

--0

-102.76%-5K

--0

Financing cash flow

Cash flow from continuing financing activities

25,343.69%26M

750.41%4M

327.35%2M

-100.31%-103K

-115.58%-615K

-91.93%468K

-99.81%44K

-37.02%33.33M

1,447.84%3.95M

Net issuance payments of debt

--6M

--4M

----

--0

----

Net common stock issuance

19,518.45%20M

--0

-100.31%-103K

-115.77%-615K

-91.90%468K

--0

-99.81%44K

-36.88%33.23M

30,100.00%3.9M

Proceeds from stock option exercised by employees

----

--0

-64.06%101K

-82.46%47K

Cash from discontinued financing activities

Financing cash flow

25,343.69%26M

750.41%4M

327.35%2M

-100.31%-103K

-115.58%-615K

-91.93%468K

--0

-99.81%44K

-37.02%33.33M

1,447.84%3.95M

Net cash flow

Beginning cash position

-92.70%2.72M

-79.01%2.42M

-63.77%7.38M

-11.87%37.34M

-72.05%11.51M

-54.47%20.38M

-51.39%27.4M

-11.87%37.34M

152.08%42.37M

-16.07%41.18M

Current changes in cash

107.11%2.46M

131.24%2.74M

43.83%-4.98M

-588.03%-34.62M

-128.48%-8.79M

-148.44%-8.87M

39.51%-7.02M

-171.04%-9.94M

-119.68%-5.03M

42.60%-3.85M

Effect of exchange rate changes

--26K

--52K

--15K

----

End cash Position

91.34%5.21M

-79.01%2.42M

-92.70%2.72M

-72.05%11.51M

-54.47%20.38M

-51.39%27.4M

-11.87%37.34M

Free cash flow

14.56%-29.49M

11.83%-7.2M

25.22%-6.98M

10.04%-34.51M

-4.83%-8.17M

0.36%-9.34M

39.20%-7.02M

-3.47%-9.98M

-39.06%-38.36M

-12.21%-7.79M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021	(Q4)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	14.56%-29.49M	11.83%-7.2M	25.22%-6.98M	10.03%-34.51M	-4.83%-8.17M	0.34%-9.34M	39.18%-7.02M	-3.47%-9.98M	-39.27%-38.36M	-11.75%-7.79M
Net income from continuing operations	-26.46%-48.07M	-152.62%-24.67M	27.94%-7.34M	5.57%-38.01M	2.81%-9.77M	-3.97%-10.19M	25.89%-8.03M	-4.80%-10.03M	-33.53%-40.25M	-6.93%-10.05M
Operating gains losses	--5.85M	--5.97M	---17K	----	----	----	----	----	----	----
Depreciation and amortization	127.78%369K	451.22%226K	10.00%44K	-3.57%162K	46.43%41K	-13.04%40K	172.86%51K	-81.71%30K	-7.69%168K	-36.36%28K
Other non cash items	--9.87M	--9.8M	----	----	----	----	----	----	----	----
Change In working capital	3.01%1.13M	18.00%1.45M	-40.82%174K	214.99%1.1M	-18.62%1.23M	281.48%294K	117.03%205K	42.57%-630K	-211.71%-954K	-20.87%1.51M
-Change in receivables	200.00%234K	--0	--0	-134.36%-234K	-128.15%-105K	-76.08%133K	149.47%376K	-224.61%-638K	421.23%681K	505.43%373K
-Change in prepaid assets	-166.80%-1.49M	-91.21%99K	-94.27%45K	290.12%2.23M	202.69%1.13M	154.51%785K	-4,494.44%-827K	1,404.55%1.15M	-14.09%-1.17M	-57.97%372K
-Change in payables and accrued expense	498.01%2.6M	1,215.89%1.41M	126.65%145K	-41.65%-653K	-85.99%107K	-175.35%-544K	316.90%924K	25.05%-1.14M	-122.00%-461K	-40.17%764K
-Change in other current assets	396.18%1.43M	1,626.47%1.17M	140.82%118K	--288K	--68K	--49K	----	----	----	----
-Change in other current liabilities	-206.16%-1.64M	-3,950.00%-1.23M	-3.88%-134K	---536K	--32K	---129K	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	14.56%-29.49M	11.83%-7.2M	25.22%-6.98M	10.03%-34.51M	-4.83%-8.17M	0.34%-9.34M	39.18%-7.02M	-3.47%-9.98M	-39.27%-38.36M	-11.75%-7.79M
Investing cash flow
Cash flow from continuing investing activities	297,400.00%5.95M			60.00%-2K					-102.76%-5K	0
Net PPE purchase and sale	----	----	----	----	----	----	----	----	88.89%-5K	--0
Net business purchase and sale	--1.91M	----	----	--0	----	----	----	----	----	----
Net investment purchase and sale	----	----	----	----	----	----	----	----	--0	----
Net other investing changes	201,950.00%4.04M	----	----	---2K	----	----	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	297,400.00%5.95M	----	----	60.00%-2K	----	----	----	--0	-102.76%-5K	--0
Financing cash flow
Cash flow from continuing financing activities	25,343.69%26M	750.41%4M	327.35%2M	-100.31%-103K	-115.58%-615K	-91.93%468K	0	-99.81%44K	-37.02%33.33M	1,447.84%3.95M
Net issuance payments of debt	--6M	--4M	----	--0	--0	----	----	----	----	----
Net common stock issuance	19,518.45%20M	--0	--0	-100.31%-103K	-115.77%-615K	-91.90%468K	--0	-99.81%44K	-36.88%33.23M	30,100.00%3.9M
Proceeds from stock option exercised by employees	----	----	----	----	----	----	----	--0	-64.06%101K	-82.46%47K
Cash from discontinued financing activities
Financing cash flow	25,343.69%26M	750.41%4M	327.35%2M	-100.31%-103K	-115.58%-615K	-91.93%468K	--0	-99.81%44K	-37.02%33.33M	1,447.84%3.95M
Net cash flow
Beginning cash position	-92.70%2.72M	-79.01%2.42M	-63.77%7.38M	-11.87%37.34M	-72.05%11.51M	-54.47%20.38M	-51.39%27.4M	-11.87%37.34M	152.08%42.37M	-16.07%41.18M
Current changes in cash	107.11%2.46M	131.24%2.74M	43.83%-4.98M	-588.03%-34.62M	-128.48%-8.79M	-148.44%-8.87M	39.51%-7.02M	-171.04%-9.94M	-119.68%-5.03M	42.60%-3.85M
Effect of exchange rate changes	--26K	--52K	--15K	----	----	----	----	----	----	----
End cash Position	91.34%5.21M	91.34%5.21M	-79.01%2.42M	-92.70%2.72M	-92.70%2.72M	-72.05%11.51M	-54.47%20.38M	-51.39%27.4M	-11.87%37.34M	-11.87%37.34M
Free cash flow	14.56%-29.49M	11.83%-7.2M	25.22%-6.98M	10.04%-34.51M	-4.83%-8.17M	0.36%-9.34M	39.20%-7.02M	-3.47%-9.98M	-39.06%-38.36M	-12.21%-7.79M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data